Filing Details
- Accession Number:
- 0001628280-24-047644
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-13 16:41:55
- Reporting Period:
- 2024-11-08
- Accepted Time:
- 2024-11-13 16:41:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1756655 | Ardent Health Partners Inc. | ARDT | Services-General Medical & Surgical Hospitals, Nec (8062) | 611764793 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1951658 | Thomas Robert Webb | 340 Seven Springs Way, Suite 100 Brentwood TN 37027 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-11-08 | 10,000 | $17.47 | 30,275 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2024-11-08 | 10,000 | $16.49 | 40,275 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price of $17.47 per share. These shares were purchased in multiple transactions on 11/08/2024 at prices ranging from $17.425 to $17.50, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price of $16.49 per share. These shares were purchased in multiple transactions on 11/08/2024 at prices ranging from $16.42 to $16.51, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.